Research Sources
Our approach to scientific information and the authoritative sources we prioritize across this educational resource.
Peptide science is a rapidly developing field.
The purpose of RE-Movement Peptide Science & Education is to help patients understand what researchers are studying while maintaining a clear distinction between:
Our Approach to Scientific Information
- •Established medical evidence
- •Human clinical research
- •Early-stage research
- •Preclinical or laboratory research
- •Scientific theory
- •Areas where evidence remains limited
Primary Regulatory Sources
U.S. Food and Drug Administration — FDA
Used for information concerning FDA approval status, drug labeling, compounding regulations, regulatory actions, safety communications, advisory committee activity, and drug and biological product information.
National Institutes of Health — NIH
Used for federally supported medical and scientific information and research resources.
Scientific Literature
PubMed is a primary resource for searching peer-reviewed biomedical and life-science literature. Research referenced throughout this website may include:
- •Systematic reviews
- •Randomized clinical trials
- •Human clinical studies
- •Observational studies
- •Pharmacological studies
- •Mechanistic research
- •Preclinical studies
- •Laboratory research
Clinical Research
ClinicalTrials.gov is used to identify registered clinical studies involving medications, peptides, biological pathways, and emerging therapies.
The existence of a clinical trial does not establish that a treatment has been proven safe or effective.
Peer-Reviewed Medical and Scientific Journals
Where appropriate, content may reference research published in recognized peer-reviewed journals.
Individual research profiles should identify the underlying sources whenever practical so readers can review the scientific literature directly.
Evidence Matters
Not all scientific studies carry the same weight. Whenever possible, RE-Movement considers factors such as:
- •Human research vs. animal or laboratory research
- •Study size
- •Study design
- •Presence of a control group
- •Peer review
- •Replication of results
- •Consistency with other research
- •Regulatory status
What Research Does Not Mean
A published study does not automatically mean that a compound is:
- •FDA-approved
- •Proven effective
- •Proven safe
- •Available for medical use
- •Appropriate for every patient
- •Recommended by RE-Movement
Regulatory Information Can Change
Peptide regulation and compounding requirements continue to evolve.
Information presented on this website reflects the sources available at the time the educational content is prepared or reviewed.
Future regulatory status, availability, or FDA approval cannot be predicted.
Our Standard
Our goal is not to make emerging science sound more certain than it is. We believe patients deserve to know:
- •What researchers are studying.
- •What evidence currently exists.
- •How strong that evidence is.
- •What remains uncertain.
- •And where the science may be heading next.
Our Principle
FOLLOW THE SCIENCE. UNDERSTAND THE EVIDENCE. STAY INFORMED.